Greater Cannabis 1-for-1,500 split; trades as GCAND for 20 days

Rhea-AI Filing Summary

The Greater Cannabis Company (GCAN) is implementing a 1-for-1,500 reverse stock split of its common stock, effective as of the close of business on October 15, 2025. The stock will begin trading on a post-split basis on October 16, 2025 under the temporary ticker GCAND for twenty trading days, with a new CUSIP 391657202.

The reverse split reduces issued and outstanding common shares from 1,349,888,436 to approximately 900,256. No fractional shares will be issued; holders entitled to a fraction will receive one whole share. The action also applies to shares issuable upon conversion of outstanding convertible debt, warrants, and options. Authorized shares and par value ($0.001) remain unchanged, and the company notes it will have additional shares available for potential future issuance, without specific plans beyond honoring existing convertible and equity awards.

Insights

Corporate actions analyst

Large reverse split consolidates shares; authorized stock unchanged.

GCAN will execute a 1-for-1,500 reverse split effective October 15, 2025, with post-split trading starting October 16, 2025 as GCAND for twenty trading days. Outstanding common shares move from 1,349,888,436 to approximately 900,256, and fractional entitlements are rounded up to a whole share. The change also applies to shares issuable from convertible debt, warrants, and options.

Authorized shares and $0.001 par value remain unchanged, which means more authorized but unissued shares become available after consolidation. The company states it may use additional authorized shares in the future to raise capital but has no specific plans beyond satisfying conversions and exercises referenced here.

false --12-31 0001695473 0001695473 2025-10-15 2025-10-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 15, 2025

The Greater Cannabis Company Inc.

(Exact name of registrant as specified in charter)

Florida		000-56027		30-0842570
(State or other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

15 Walker Ave, Suite 101, Baltimore, MD		21208
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (443)-738-4051

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of Company under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		GCAN		None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

As used in this Current Report on Form 8-K, and unless otherwise indicated, the terms “the Company,” “GCAN,” “we,” “us” and “our” refer to The Greater Cannabis Company, Inc. and its subsidiaries.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The disclosure set forth in Item 8.01 of this Current Report on Form 8-K is incorporated into this item by reference.

Item 8.01 Other Matters.

Reverse Stock Split

We are implementing a 1-for-1,500 Reverse Split of the Company’s common stock (the “Reverse Split”) effective as of the close of business on October 15, 2025. As a result, every 1,500 pre-Reverse Split shares of common stock outstanding will automatically combine into one new share of post-Reverse Split common stock without any action on the part of the holders.

The Company’s common stock will begin trading on a post-Reverse Split basis at the opening of trading on Thursday, October 16, 2025. In connection therewith, the Company’s ticker symbol will be GCAND for twenty (20) trading days to designate that it is trading on a post-Reverse Split basis. In addition, our post-Reverse Split common stock will trade under the new CUSIP Number 391657202.

Following the Reverse Split, the number of shares of the Company’s issued and outstanding common stock will have been reduced from 1,349,888,436 to approximately 900,256. The Reverse Split will also apply to shares of common stock issuable upon the conversion of outstanding convertible debt, warrants and stock options. No fractional shares of common stock will be issued as a result of the reverse stock split. Instead, the Company will issue one whole share of the post-reverse stock split common stock to any stockholder who otherwise would have received a fractional share as a result of the reverse stock split. The number of authorized common stock shall remain unaffected and the par value shall remain at $0.001 per share.

There is not a requirement that stockholders obtain new or replacement share certificates. Each of the holders of record of shares of the Company’s common stock that is outstanding on the effective date of the reverse stock split may contact the Company’s transfer agent to exchange the certificates for new certificates representing the number of whole shares of post-reverse stock split common stock into which the existing shares of common stock have been converted as a result of the reverse stock split.

Upon the completion of the reverse stock split, the Company will have additional shares of common stock available for issuance. Although the Company may use the additional authorized shares of common stock in the future to raise additional capital, it has no specific plans, arrangements, or understandings to do so beyond making shares available for issuance pursuant to the conversion of outstanding convertible debt and the exercise of outstanding options and warrants, if applicable.

In connection with the reverse stock split, we filed Articles of Amendment to our Articles of Incorporation with the Secretary of State of Florida, a copy of which is included as Exhibit 3.1 to this Report.

The Company expects that shareholders holding GCAN shares at registered brokerage firms or at the transfer agent will have the Reverse Split transaction processed automatically in their accounts over the next few days. Shareholders holding physical stock certificates may request new certificates evidencing their post-Reverse Split shares by contacting the Company’s transfer agent, ClearTust, LLC, 16540 Pointe Village Dr, Suite 210, Lutz, Florida 33558, cleartrustonline.com or (813) 235-4490.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
3.1		Articles of Amendment to Articles of Incorporation of The Greater Cannabis Company, Inc.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: October 15, 2025	THE GREATER CANNABIS COMPANY INC.
	By:	/s/ Aitan Zacharin
		Aitan Zacharin Chief Executive Officer

2

FAQ

What reverse split did GCAN announce and when is it effective?

GCAN approved a 1-for-1,500 reverse stock split, effective at the close of business on October 15, 2025.

When will GCAN trade post-split and under what ticker?

Post-split trading begins on October 16, 2025 under temporary ticker GCAND for twenty trading days.

How many GCAN shares will be outstanding after the reverse split?

Issued and outstanding common shares will be reduced from 1,349,888,436 to approximately 900,256.

How are fractional GCAN shares handled in the reverse split?

No fractional shares will be issued; any holder otherwise entitled to a fraction will receive one whole share.

Does the reverse split change GCAN’s authorized shares or par value?

No. Authorized common stock and $0.001 par value remain unchanged.

Does the reverse split affect convertible debt, warrants, and options?

Yes. It also applies to shares issuable upon conversion of convertible debt, and the exercise of warrants and options.

What is the new CUSIP for GCAN’s post-split common stock?

The post-split common stock will trade under CUSIP 391657202.